DPHil Students: Carl welcomes informal contacts from prospective students interested in using evidence-based approaches to improve healthcare in the following areas:
- NonCommunicable Diseases, self care and multimorbidity
- Evidence synthesis and systematic reviews
- Implementation in Primary Care settings
- Diagnosis and overdiagnosis
- Public understanding of EBM
- Improving drug and device regulation
All students gain the opportunity to teach, participate in the CEBM's dissemination, media activities and related projects.
BM, BCH, MA, MRCGP, DPhil
Professor of Evidence-Based Medicine
- Director of the CEBM
- Director of Programs in EBHC
- NHS Honorary Clinical Consultant & Urgent Care GP
- Editor in Chief BMJ EBM
- NIHR Senior Investigator
Carl is a clinical epidemiologist and leading expert in Evidence-Based Medicine, research methods and regulatory science.
He has extensive experience in Systematic reviews and is Director of the NIHR SPCR Evidence Synthesis Working Group, a collaboration of nine UK primary care departments.
His work includes investigating drug and devices, advising governments on regulatory evidence and evidence-based healthcare projects in the public interest. He has worked with BBC Panorama to examine the evidence for sports drinks and IVF 'Add-on' treatments, and with the media to investigate problems with metal-hips, mesh and Essure. He is a member of the UK's Parliaments Mesh All Parliamentary Party Group and is an advisor to the WHO, US FDA and the UK government amongst others. He led the Tamiflu systematic reviews, and he is Director of a World Health Organization Collaborating Centre that aims to improve the evidence for NonCommunicable Diseases
He is a founder of the AllTrials campaign, has chaired WHO guidelines on self-care and CVD risk, is a co-PI on four multi-centre RCTs and chair of two NIHR Trial Steering Committees. Twice he has been voted one of the top 100 NHS clinical leaders by the HSJ. He is a board member of the NIHR School for Primary Care Research. In 2018 he was awarded NIHR Senior Investigator status - considered the most prominent and prestigious researchers funded by the NIHR and the most outstanding leaders of patient and people-based research within the NIHR Faculty.
Carl is Director of the Centre for Evidence-Based Medicine (CEBM). CEBM devotes a significant proportion of its time to capacity building through outreach teaching and training activities. He teaches undergraduates, postgraduates and teachers of EBM, and is the Director of Programs in Evidence-Based Health Care. The program has over 130 MSc and 30 DPhil students, As Director of CEBM he oversees the Teaching Evidence-Based Practice wee - the course has trained over 1000 teachers worldwide.
He is Editor in Chief of the Journal BMJ Evidence-Based Medicine, which has a dedicated blog site (BMJ EBM Spotlight) and twitter account @BMJ_EBM. The journal publishes original evidence-based research, insights and opinions on what matters for health care.
Carl has over 300 peer-reviewed publications and co-authored the EBM toolkit and Statistics Toolkit (BMJ-Blackwell’s) and, developed with the BMJ the ‘Doctors Toolbag’ iPhone application and the EvidenceLive conference, now in its 8th year.
Professor Heneghan has extensive experience in both print and broadcast media. He is a regular contributor to BBC Radio 4's Inside Health series and in 2016 worked with the BBC's Panorama on Inside Britain's Fertility Business.
He runs an active twitter account (@carlheneghan)
Conflicts of interest and payments:
Carl has received expenses and fees for his media work (including payments from BBC Radio 4 Inside Health). He has received expenses from the WHO, FDA, and holds grant funding from the NIHR, the NIHR School of Primary Care Research, The NIHR BRC Oxford and the WHO. He has received financial remuneration from an asbestos case and given free legal advice on mesh cases. He has also received income from the publication of a series of toolkit books published by Blackwells. On occasion, he receives expenses for teaching EBM and is also paid for his GP work in NHS out of hours (contract with Oxford Health NHS Foundation Trust). He is Director fof CEBM, which jointly runs the EvidenceLive Conference with the BMJ and the Overdiagnosis Conference with international partners, based on a non-profit making model. He is Editor in Chief of BMJ Evidence-Based Medicine ,and is an NIHR Senior Investigator.
Barbour V. et al, (2016), Trials, 17
Post-Marketing Withdrawal Of Medicines Because of Adverse Drug Reactions: An Analysis of Anti-Obesity Medications
Onakpoya I. et al, (2015), DRUG SAFETY, 38, 1016 - 1017
Ward A. et al, (2015), Br J Gen Pract, 65, e428 - e437
Gbinigie O. et al, (2019), Trials, 20
Improving the detection, analysis, and reporting of harms in medicines and devices – Statement from the 2019 4Es Forum
Richards G. et al, (2019)
Aronson JK. et al, (2019), Drug Saf